16Jun
Diligence Clauses and the Management of Uncertainty in Life Sciences Agreements
In times of uncertainty and disruption, setting expectations for performance with business partners and contractual counterparties can be more complicated than ever. Companies that develop drugs, biologics and medical devices have considerable...
By:
Skadden, Arps, Slate, Meagher & Flom LLP
Related
McDermott continues to provide the latest market updates on the disruption and uncertainty in the en...
Read More >
In its decision, the Court concluded that UnitedHealth Group, Inc. (“United”) was not authorized t...
Read More >
Governor Newsom proposes new plan for San Joaquin River Delta - Governor Gavin Newsom revealed a n...
Read More >
In a highly unfavorable peer review decision, Leadbitter v. Keystone Anesthesia v. Petraglia, entere...
Read More >
The United States Department of Labor today released new regulations that dramatically change the ex...
Read More >
The Supreme Court’s October 2018-2019 term began with the highly politicized confirmation of Justic...
Read More >